...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Trillium

aaacchhhhhhh,,,,,,,jmo,,,but,,,,,,,,DMcC seems to have no influence in any business arrangements either wished for or in progress. He is simply the company mascot who is remote from the actual details happening within these two companies. It works great for major insiders,,,,not so much for us retails shareholders. The sales pitches have been none stop over the years and were only baseless promotions by a symposium planner. No credentials to deal in any form of complicated discussions, and having no previous experience in such supports this theory. This should be obvious to investors these past 6 quarters since the BoM results. I rule out nothing in our future, good or bad! Its the major insiders who will define our fate!

Share
New Message
Please login to post a reply